International Journal of Immunology is a peer-reviewed open access journal that publishes original research articles as well as review articles in all areas of immunology. Immunology is a diverse and growing discipline that can be defined as the study of the tissues, cells and molecules involved in host defense mechanisms. Immunologists attempt to understand how the immune system develops, how the body defends itself against disease, and what happens when it all goes wrong. Priority is given to work that provides fundamental insight into the workings of the immune system. Areas covered include, but are not limited to, innate immunity and inflammation; development; immune receptors, signaling and apoptosis; antigen presentation; gene regulation and recombination; cellular and systemic immunity; vaccines; immune tolerance; autoimmunity and tumor immunology, microbial immunopathology; and transplantation.

The great advances in immunology in recent years make this field one of the most dynamic and rapidly growing in biological sciences. This remarkable growth is stimulated by the influx of investigators from other disciplines such as biochemistry, genetics, molecular biology, microbiology, virology and various medical disciplines. These disciplines are so well interlinked with immunology that no immunological challenge can now be properly addressed without sophisticated applications of expertise of combinations of these disciplines. As a consequence, immunology has become a vast and rich field encompassing discoveries and outlooks that range from the highly clinical to the highly molecular. Although such perspectives may appear diverse, they are, in fact, extremely interdependent. The journal seeks to present a balanced overview of contemporary immunology and melds together different aspects of molecular immunology, immunobiology and clinical immunology.

Immunology is the branch of biomedical science that deals with the response of an organism to antigenic challenge and its recognition of what is self and what is not. It deals with the defense mechanisms including all physical, chemical and biological properties of the organism that help it to combat its susceptibility to foreign organisms, material, etc

Immunology has its origins in the study of how the body protects itself against infectious diseases caused by microorganisms, such as bacteria, viruses, protozoa, and fungi, and also parasitic organisms, such as helminth worms. Research / review articles deals with, among other things, the physiological functioning of the immune system in states of both health and disease; malfunctions of the immune system in immunological disorders (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection); the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo are of prime interest.


committee

Members

ThumbnailImage

ISHTIAQ QADRI

Professor and Head Virology

INSTITUTION AND LOCATION

DEGREE

YEAR(s)

FIELD OF STUDY

Center for Biotechnology, Dept. of Biochemistry, Imperial College of Science, Technology and Medicine, University of London, London, SW7 2AZ, UK.

PhD

1984-1988

Molecular Biology  [Transposable element, Tn7 and bacteriophage M13]

Department of Stomatology/Microbiology

University of California San-Francisco (UCSF), CA, Joint project with Stanford University, Stanford, CA, 94813 USA

Post-doctoral Fellow

1988-1993

Virology [human herpes viruses (HSV-1 & HCMV)]

Department of Microbiology

University of Colorado Health Sciences Center (UCHSC), Denver, CO, 80262 USA.

Senior Post –doctoral Fellow

1994-1997

Virology (Hepatitis B Virus, yeast Ty-1 element)

  1. 1984-1988    :     Quaid-i-Azam Award for securing the top position in the Quaid- i-Azam university Islamabad, Pakistan (Total US $ 70,000) (Single Award)
  2. 1985-1988    :     University Grants Commission Award for overseas students, London, UK (Total US $ 80,000).
  3. 1990-1991    :     UC-California Cancer League Award, San Francisco, CA, USA (Total, US $ 25,000)
  4. 1991-1992    :     UC-California Cancer League Award, San Francisco, CA, USA (Total, US $ 23,500)
  5. 1995-1996    :     American Cancer Society -Internal Review Grant UCHSC, Denver, CO, USA (Total US $ 18,500)
  6. 1997-1998    :     Colorado League of Cancer Grant, Denver, CO, USA (Total US $ 20,000)
  7. 1999-2000    :     UCHSC Thorkelson Award (Single Award), Denver, CO, USA (Total US $ 25,000)
  8. 2000-2003    :     American Liver Foundation Herman Lopeta Memorial Award, New York, NY, USA
    (Total US $ 150,000)
  9. 2000-2005    :     NIH RO1 [PI: F. Simon, MD, (80%) & Co Investigator; I. Qadri, PhD (20%)]
    (Total US $ 1,250,000)
  10. 2004             :     AMGEN young Investigator Award on Liver transplantation,  Breckenridge, CO, (US $ 5000)
  11. 2006             :     Travel Award Snow Mass Conference on Liver diseases, CO, USA (Total US $ 3,000)
  12. 2007-2008    :     Higher Education Commission (HEC) Grant, Islamabad, Pakistan: Cloning of Hepatitis C Virus E1/E2 (Total US $ 17,000)
  13. 2008-2009    :     Pak-France Grant: Construction and Characterization of infectious Hepatitis Virus Chimera (Total US $ 70,000), in collaborations with Pasteur Institute, Lille France.   
  14. 2007-2009    :     Higher Education Commission (HEC) Grant, Islamabad, Pakistan: Development of Cellular model for Pakistani hepatitis C Virus Infection for mechanistic studies and vaccine/drug testing  (Total US $ 73,571)
  15. 2007-2009    :     Ministry of Science & Technology (MOST) and Higher Education Commission  of Pakistan, Islamabad, Pakistan: Establishment of NUST Center of Virology and Immunology (NCVI), Islamabad, Pakistan, (Total US $ 640,000)
  16. 2008-2010    :     Pak-US Science and Technology Cooperative Program: Hepatitis C Virus (HCV) Management in Pakistan (Total US $ 300,500), jointly with Rockefeller University New York, NY, USA.
  17. 2009-2010    :     Higher Education Commission of Pakistan; Procurement of a high speed  centrifuge (Total US $ 12,500)
  18.  2009-2010   :     National University of Science and Technology; Islamabad, Pak  Functional  Cloning of Pakistani Dengue Virus Genome for Antiviral Testing  (Total US $ 17,000)
  19. 2009-2012    :     Using Nanotechnology to purify water from deadly viruses. Ministry of Science and Technology, Islamabad, (US $ 90,000)
  20. 2009-2010    :     Pakistan Science Foundation Islamabad: Cloning and characterization of full  length Dengue virus Genome of Pakistani origin (Total US $  24,600)
  21. 2010-2013    :     Peptide Vaccination against Hepatitis C Virus NS3 Protein (US $113,000) Higher Education Commission of Pakistan
  22. 2011-2014    :     Pak-US Science and Technology Cooperative Program: Hepatitis B Virus (HBV) Induced Hepatocellular Carcinoma in Pakistan (Total US $ 780,500) jointly with University of California San-Diego, CA, USA
  23. 2011             :     1st Annual Symposium Grant on  “HCV Management in Pakistan”  (US $ 5,117) Higher Education Commission of  Pakistan
  24. 2011             :     Travel Grant on Pakistan US. Science & Technology Conference (March 21-24, 2011) Dubai UAE (US $ 5,000) US National Academics, USA
  25. 2011             :     To study the immunomodulatory effect of calcitriol (1.25-dihydroxyvitamin D3, 1,25 (OH)(2)D(3)) on pro-inflammatory status of activated immune cells in Pakistani Type 1 diabetic population. PI Dr. Sheeba Murad Co-PI Dr. Ishtiaq Qadri (US $ 0.059) Higher Education Commission of  Pakistan
  26. 2011-2014    :    Development and Validation of Transgenic Virus Resistance in Nicotiana Benthamiana by expression of artificial micro RNA (amiRNA) carrying begomovirus (Tomato leaf curl New Delhi Virus) derived sequences. PI Dr. M. Tahir Co-PI Dr. Ishtiaq Qadri (US $ 68600) Higher Education Commission of  Pakistan
  27. 2011-2013    :    Structural and functional analysis of hepatitis C virus NS3/NS4A proteins: potential target for antiviral therapy. Pak-Egypt joint Grant (US $ 80,000). PI Dr. Ishtiaq Qadri and Dr. Waleed Morsey
  28. 2013-215      :    Deciphering the molecular Mechanism of Interferon resistance in HCV GT-4 infected individuals. KACST large grant (US $ 320,000) , KACST,  Riyadh Saudi Arabia
  29. 2016-2017    :    Acoustic and hybrid 3D prinitng of liver cancer stem cells (SAR 350,000) WAQF, KAU, Jeddah
  30. 2017-2018    :    To understand the mechanism o insecticide resistance in A. egypti SAR 34,500. DSR, KAU, Jeddah, KSA

peer-reviewed International publications (IMPACT FACTOR  ~380, RG -Citation 2500, Google Citation 3500 ) https://www.researchgate.net/profile/Ishtiaq_Qadri

  1. Qadri, I., Khan, W., Haider, Z.Y and Khanum, A. (1985) Identification of cAMP binding proteins in the Leydig cells and somniferous tubules of mouse testis. Pak J. Zoo 4, 339-348. Impact factor 0.73
  2. Qadri, I., Khan, W., Haider, M.Z.-Y and Khanum, A. (1987) Mechanism of cAMP transfer in the Leydig cells and somniferous tubules of mouse testis.  Pak J. Zoo 19, 63-68.  Impact factor 0.73
  3. Qadri, I., Flores, C., Davies, A and Lichtenstein, C. (1989) Genetic analysis of attTn7, the transposon Tn7 attachment site, using a novel M13 based transduction assay.  Journal of Molecular Biology 207, 85-97. Impact factor 4.1
  4. Flores, C., Qadri, I and Liechtenstein, C. (1990) DNA sequence analysis of five genes; TnsA, B, C, D and E required for Tn7 transposition.  Nucleic Acids Research 18, 901-911. Impact factor 9.112
  5. Pereira, L., Qadri, I., Navarro, D and Gimeno, C. (1990)  Antigenic and structural properties of mutants in Herpes Simplex virus -1 glycoprotein B. Advances in  Experimental  Medical Biology. 278, 165-82. Impact factor 1.4
  6. Qadri, I., Gimeno, C., Navarro, D and Pereira, L. (1991) Mutations in conformation-depended domains of HSV-1 glycoprotein B affect the antigenic properties, dimerization and transport of the molecule. Virology 180, 135-152. Impact factor 3.33
  7. Navarro, D., Qadri, I and Pereira, L. (1991) A mutation in the ectodomain of herpes simplex-1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum.  Virology 184, 253-264. Impact factor 3.32
  8. Wooden, S. K., Li, L., Navarro, D., Qadri, I., Pereira, L and Lee, A. (1991) Transactivation of the GRP78 promoter by malfolded proteins, glycosylation block and calcium ionophore is mediated through a proximal region containing a CCAATT motif which interacts with CTF/NF1. Molecular Cellular Biology 11, 5612-5623. Impact factor 5.28
  9. Qadri, I., Navarro, D., Paz, P and Pereira, L. (1992) Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J. Gen. Virol.  73, 2913-2921.  Impact factor 3.36
  10. Perieria, L., Bascoz, N., Navarro, D., Qadri, I., Youngblom, J., Sears, A and Lennette, E. (1992) Mapping conserved antigenic regions and strain-specific epitopes within the glycoprotein B gene of human cytomegalovirus.  In P. Landini (Ed), Progress in Cytomegalovirus Research Excerpta Medica international Congress series, Elsevier Science Publisher, pp. 195-198. Impact factor 1.32
  11. Bascoz, N., Qadri, I., Navarro, D., Youngblom, J., Sears, A., Lennette, E and Pereira, L. (1992) The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. Journal of  General Virology 73, 983-988. Impact factor 3.36
  12. Navarro, D., Qadri, I., Pereira, L. (1993) Transport and secretion of truncated derivatives of herpes simplex-1 glycoprotein B. and I  Virology  192, 234-245. Impact factor 3.32
  13. Tugizov, S., Navarro, D., Paz, P., Wang, Y., Qadri, I and Pereira, L. (1994) Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.  Virology 201, 263-276. Impact factor 3.32
  14. Tugizov, S., Wang, Y., Qadri, I., Navarro, D., Maidji, E and Pereira, L.  (1995) Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology 209, 580-591. Impact factor 3.32
  15. Qadri, I., Maguire, H.F and Siddiqui, A. (1995) The Hepatitis B virus transactivator protein X interacts with the TATA binding protein, TBP. Proceedings of the National Academy of Science (USA) 92, 1003-1007. Impact factor 9.674
  16. Qadri, I., Ferrari, M and Siddiqui, A. (1996) Hepatitis B virus transactivator protein, HBx interacts with single-stranded DNA: Biochemical characterizations of HBx-ssDNA interactions. Journal of Biological Chemistry. 271 (26), 15443-15550. Impact factor 4.753
  17. Qadri, I., Conaway, JW., Conaway, RC., Schaack, J and Siddiqui, A. (1996) Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH.  Proceedings of the National Academy of Science (USA)  93, 10578-10583. Impact factor 9.67
  18. Kosovsky, M., Qadri, I and Siddiqui, A. (1998) The regulation of hepatitis B virus gene expression: An overview of the cis- and trans- acting components in Hepatitis B virus: molecular mechanisms in disease and novel strategies for gene therapy". (Koshy and Caselmann, Eds), IC Press, London, pp. 16-44. Impact factor 1.6
  19. Qadri, I and Siddiqui, A. (1999) Expression of hepatitis B virus polymerase in Sacchromyces cerivisiae using a novel Ty1-his3AI retro-element. Journal of Biological Chemistry. 274 (44), 31359-31365. Impact factor 4.763
  20. Abdel-Hafiz, H.A., Qadri, I and El-Rehany, M. (2000) Hepatitis B virus X protein activates human interleukin 6 gene in human hepatoma cells.  Egyp. Journal of Biotechnology. 18 (1), 15-21. Impact factor 0.874
  21. Shiao, T., Iwahashi, M, Fortune, J., Quattrochi, L., Bowman, S. Wick, M., Qadri, I and Simon, FR. (2000) Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter.  Genomics 69, 203-213. Impact factor 3.327
  22. Qadri, I., Iwahashi, M and Simon, FR. (2002) Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochimica et Biophysica Acta (BBA) 159,193-204. Impact factor 4.663
  23. Feranckah AP., Kilic, G., Wojtaszek, PA., Qadri, I and Fitz, GJ. (2003) Volume-sensitive tyrosine kinases regulate liver cell volume through effects on vesicular trafficking and membrane Na+ permeability. Journal of Biological Chemistry 287 (45), 44632-44638. Impact factor 4.753
  24. Qadri, I., Iwahashi, M, Cappasso, J., Hopken, M.W., Flores, S., Schaack, J and Simon, FR. (2004) Induced oxidative stress and activated expression of manganese superoxide dismutase (MnSOD) in HCV-replicating cells: role of JNK, p38MAPK, & AP-1.  Biochemical Journal 10, 417-416. Impact factor 4.4
  25. Simon, F., Fortune, J., Iwahashi, M, Qadri, Sutherland, E. (2004) Multihormonal regulation of hepatic sinusoidal sodium-dependent TAUROCHOLATE cotransporter gene expression. American Journal of Physiology Gastroenterology and Liver Physiology. 287, G782-G794. Impact factor 3.753
  26. Puljak, L., Pagliassotti, MJ. Wei, Y., Qadri, I., Fitz, J.G and Kilic, G. (2005) Insulin fails to stimulate exocytosis and Cl- conductance in a model of fatty liver; role of PKC. Journal of  Physiology (London). 10, 1113- 08033. Impact factor 5.04
  27. Kulig, C and Qadri, I. (2006) Hepatitis C virus and alcohol dependence. Recent Research Development in  Biochemistry. 81, (7736). 297-306. Impact factor 0.78
  28. Simon, FR., Iwahashi, M., Hu, L.-J., Qadri, I., Arias, I. W., Ortiz, D., Dahl, R and Sutherland, E. (2006) Hormonal regulation of hepatic multidrug resistance associated protein (ABCC-2) primarily involves the pattern of growth hormone secretion. American Journal of Physiology Gastroenterology and Liver Physiology 290, G595-G608. Impact factor 3.753
  29. Qadri, I., Iwahashi, M., Kullak-Ublic,  G.A. and Simon, F.R. (2006) Hepatocytes nuclear factors 1 and 4 (HNF1 & HNF4) mediate hepatic MRP2 up-regulation during hepatitis C virus gene expression. Molecular Pharmacology 70 (2), 627-36. Impact factor 4.13
  30. Anderson, GR., Hasan, A., Yin H., Qadri, I and Quattrochi, L. (2006) Regulation of the CYP1A1 Gene by 2,3,7,8-Tetrachlorodibenzo-p-dioxin, but not -Naphthoflavone or 3-Methylcholanthrene, is altered in hepatitis C virus replicon-expressing cells.  Molecular Pharmacology  70 (3), 1062-70. Impact factor 4.13
  31. Rahman, S.M., Schroeder-Gloeckler, J. M., Janssen, R. C., Jiang, H., Qadri I., Maclean, K.N and  Friedman, J.E. (2007). CCAAT/Enhancing Binding Protein Deletion in Mice Attenuates Inflammation, Endoplasmic Reticulum Stress, and Lipid Accumulation in Diet-Induced Nonalcoholic Steatohepatitis.  Hepatology  45 (5), 1108-17. Impact factor 11.05
  32. Sheikh, M.Y., Qadri, I., Choi, J., Friedman. J.E and Sanyal, A.J. (2008) Hepatitis C Virus Infection: Molecular Pathways to Metabolic Syndrome Hepatology   47 (6), 2127-2133. Impact factor 11.0

    Publications in 2009
  33. Qadri, I., Hu, L.-J., Iwahashi, M, Al-Zuahbi, S., Quattrochi, L and Simon, FR. (2009) Interaction of Hepatocyte Nuclear Factors In Transcriptional Regulation Of Tissue Specific Hormonal Expression Of Human Multidrug Resistance Associated Protein-2 (ABCC2).  Toxicology & Applied Pharmacology 234(3), 281-292. Impact factor 3.75
  34. Rahman, S., Qadri, I., Janssen, R. C. and Friedman, J. E. (2009) Fenofibrate and PBA prevent fatty acid- induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus- induced Steatosis. Journal of Lipid Research Nov; 50(11):2193-202. Impact factor 5.56
  35. Waheed,Y.,  Shafi, T.,  Safi, S. Z. and Qadri, I. (2009) A review of Prevalence, genotypes  and risk  factors. World Journal of Gastroenterology  15 (45), 5647-5653. Impact factor 2.43

    Publications in 2010
  36. Ali, M., Zahoor, M., Shuja, M. N and Qadri, I. (2010) Phytic acid: How far have we come? African Journal of   Biotechnology. 9 (11), 1551-1554. Impact factor 0.573
  37. Waheed, Y., Saeed, U., Safi S. Z., Chaudhry W. N and Qadri, I. (2010) Awareness and risk factors associated with barbers in transmission of Hepatitis B and C from Pakistani population. Asian Biomedicine Aug 4 (3).15-21.  Impact factor 0.33
  38. Safi, S.Z., Badshah,Y., Waheed, Y., Tahir, S., Fatima, K., Shinwari. A. and Qadri, I. (2010) Distribution of Hepatitis C Virus Genotypes, Hepatic Steatosis and their Correlation with Clinical and Virological Parameters in Pakistan. Asian Biomedicine 4 (2), 253-262. Impact factor 0.33
  39. Ahmed, T., Waheed, Y., Safi, S., Tahir., S., Fatima, K., Afzal, Sohail., Farooqui, Z and Qadri, I. (2010) Frequency of HEV contamination in the sewerage waters in Pakistan.  Journal of Infection in Developing Countries (JIDC) 23; 4(12):842-845. Impact factor 1.22

    Publication in 2011
  40. Publications in 2011Choudhury, M., Qadri I., Rahman S. M., Schroeder-Gloeckler, J., Janssen, R. C and Friedman, J. E. (2011)  C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hematoma cells.  Molecular and Cellular Endocrinology 1;331(1):102-108. Impact factor 3.61
  41. Qadri, I., Fatima, K and Hafiz, A. H.  (2011). Hepatitis B Virus HBx impedes the DNA repair via interactions with TFIIH.  BMC Microbiology 4;11:48. Impact factor 2.978
  42. Waheed, Y., Tahir, S., Ahmed, T. and Qadri, I. (2011) Sequence, comparison and phylogenetic analysis of core gene of Hepatitis C virus from Pakistani Population. African Journal of Biotechnology 9 (29), 4561-7. Impact factor 0.573
  43. Saeed, U., Waheed, Y., Anwar, A., Hussain, T., Naeem, K., Nawaz, N., Farrukh, F and Qadri, I.  (2011) In-Silico Binding of ATP to Protein Kinase C Delta: Insights into the Structure and Active Site. European Journal of Scientific Research 52 (2), 177-187. Impact factor 0.413
  44. Waheed, Y., Safi, S.Z and Qadri, I. (2011) Role of Potash Alum in HCV Transmission in Pakistani Population. Virology Journal  May 9;8(1):211.  Impact factor 2. 43
  45. Afzal, S., Tahir, S., Salman, A., Ahmed,T., Shafi, T., Zaidi, S, N. and Qadri, I. (2011) Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.  Journal of Infection in Developing Countries (JIDC) 2011 Jul 4;5(6):473-9
  46. Fatima, K., Tahir, M. and Qadri, I. (2011) Development of Robust In vitro Protease Assay for  Pakistani Hepatitis C Virus NS3. Virus Res Sep;160(1-2):230-7 impact factor 2.773
  47. Raheel, U., Faheem, M., Riaz, N.M., Kanwal, N., Javed, F., Zaidi, N. S. S and Qadri, I. (2011) Dengue Fever in Indian Subcontinent: an overview.  J. of Infection in Developing countries (JIDC) Apr 26;5(4):239-47 Impact factor 1.22
  48. Sheikh TI, and Qadri, I. (2011) Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic
    implication in Pakistan. Diagnostic Pathol. 2011 Jul 27;6:70. doi: 10.1186/1746-1596-6-70. Impact factor 3.60
  49. Fahim, M., Raheel,U., Riaz,N.M., Kanwal,N., Javed,F., Zaidi, N. S. S and Qadri, I. (2011) A molecular evaluation of Dengue Virus pathogenesis and its latest vaccine strategies. Molecular Biology Reports Aug;38(6):3731-40. Impact factor 2. 02
  50. Qadri, I. Fatima, K and Safi, S.Z. (2011) A systematic review on life cycle, genomic organization and treatment options of HCV. J. of Natural Sciences volume 1, 1-5 ISSN 2072-4659. Impact factor, not defined yet.
  51. Nasir, W., Ul-Haq, A., Safdar, S and Qadri, I. (2011) Bacteriophages; Major applications and phage therapy. J. of Natural Sciences volume 1, 14-20 ISSN 2072-4659. Impact factor, not defined yet.
  52. Ahmad, A., Ahmad, M., Jalil, S F., Kousar, R., Gauhar, Z., Malik, J. M., Ameen, M. I.,  Qadri, I., Bhatti, A and John, P (2011) Genetics of rheumatoid arthritis and future prospectus in Pakistan.  Journal of Natural Sciences volume 1, 30-32 ISSN 2072-4659. Impact factor, not defined yet.
  53. Safi, S,Z., Afzal, A.,Waheed, Y., Butt UJ, Fatima, K., Pervaiz, Y., Qadri, I. (2011) Seroprevalence of hepatitis C and human immunodeficiency viruses in blood donors of northwestern Pakistan. Asian Biomedicine Vol. 5 No. 3 June 2011; 389-392. Impact factor 0.33
  54. Manzoor, S., Idrees, M., Ashraf, J., Mehmood, A., Butt, S., Fatima, K., Akbar, H., Rehman I, U., and Qadri I. (2011) Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins. Virology Journal. 2011 Sep 8;8(1):431.  Impact factor 2. 43
  55. Tariq, H., Manzoor, S., Parvaiz, F., Javed, F., Fatima, K., Qadri, I. (2011) An overview:  In vitro models of HCV replication in different cell cultures. Infection, Genetics and Evolution 12(1):13-20. Impact factor 3.22
  56. Parvaiz, F., Manzoor, S., Tariq, H., Javed, F., Fatima, K., Qadri, I. (2011) Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance. Virology Journal 2011, 8:474 doi:10.1186/1743-422X-8-474. Impact factor 2.34
  57. Bhatti, A.,  John, P.,   Sadia, H., Ahmed, I., Qadri, I., Jalil, F., Gauhar, Z.,  Ikram, M., Malik, J. and Ahmed. M. (2011) Mapping of genes involved in rheumatoid arthritis in Pakistani patients.  CURR. OPIN. BIOTECHNOL. 22, pp. S41-S42. Impact factor 8.45
  58. Ghayyor, A.,  Zainab, M.,  Siddiqa, A.,  Qadri, I.,  Asghar, F. and  Anwar, M. (2011)  Comparison of diagnostic modalities used for the diagnosis of HPV in cervical tumors  PROG. BIOPHYS. MOL. BIOL. 44 no 13, pp. S14-S15. . Impact factor 5.45
  59. Sadia M. R., S, H.,  Mansoor, S.,  Bhatti, A.,  Anwar, M.A., John, P.,  Rana, Q.,  Qadri, I. (2011) Molecular modeling and mutational analysis of macrophage colony stimulating factor   CURR. OPIN. BIOTECHNOL. 22, pp. S60-S60. Impact factor 8.45
  60. Sadia, H., Jamal, M.,  Bhatti, A., Anwar, M, A., ,  Siddiqui R.T.,  Qadri  I. (2011) Paucity of FLT 3-internal tandem duplications in patients with AML, ALL and CML  CURR. OPIN. BIOTECHNOL. 22, pp. S102-S102. Impact factor 8.45
  61. Afzal, M.S., Tahir, S., Salman, A,, Baig T,A,, Shafi. T, Zaidi N, U.,  and  Qadri, I, (2011). Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. Journal of Infection in Developing Countries (JIDC). 2011 Jul 4;5(6):473-9. Impact factor 1.2

    Publications in 2012
  62. Afzal M.S, Anjum, S., Farooqi, Z. R,  Noreen, M., Safi, S.Z. and Qadri I. (2012) Influence of IL-10 polymorphism on the development of coronary artery disease in Pakistan Asian Biomedicine Vol. 6 No. 2; 159-165. Impact factor 0.33
  63. Chaudhry W. N., Ul-Haq, I., Andleeb, S. and Qadri, I.  (2012) Isolation and partial characterization of a virulent bacteriophage IHQ1 specific for Aeromonas punctata from stream water. Microbial  Ecology May;63(4):954-63. doi: 10.1007/s00248-011-9944-2. Impact factor 3. 875
  64. Qadri, I., Chouradry, M.,  Rahman, S, M., Knotts, T. A., Janssen, R C., Iwahashi, M., Puljak, L., Simon, F. R., Kilic, G., Fitz, G. J and Friedman, J. E. (2012) Increased Phosphoenolpyruvate Carboxykinase Gene Expression and Steatosis during Hepatitis C Virus Subgenome Replication: Role of nonstructural component 5a and ccaat/enhancer-binding protein β.  Journal of Biological Chemistry (JBC) Oct 26;287(44):37340-51. doi: 10.1074/jbc.M112.384743. Impact factor 4.573
  65. Raza, A., Mehmood K., Begum, F, Babar, M. M., Riaz, S., , Javeda, U., , Rehman, Z,.  Zaidi, S,S., Siddiqui A, and Qadri. I., (2012) Immunological profiling of Hepatitis B virus surface gene in Pakistan. Novus International Journal of  Biotechnology & Bioscience  1 (2) 1-1 Impact factor, not defined yet.
  66. Fatima, K., Paracha R,Z, and Qadri I. (2012) Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic leukemic cells of B-CLL patients. Molecular Biology Report 2012 May;39(5):5059-67. impact factor 2.1
  67. Akhtar,  H., Badshah, Y,, Akhtar, S., Kanwal, N., Akhtar, M,N.,  Zadhi N.S., and Qadri. I.  (2012) Prevalence of human immunodeficiency virus infection among transgender men in Rawalpindi (Pakistan) Virology Journal  2012 Oct 8;9:229. doi: 10.1186/1743-422X-9-229. Impact factor 2.343
  68. Haq, I.U., Chaudhry, W.N., Akhtar, M.N., Andleeb, S., and Qadri I. (2012) Bacteriophages and their implications on future biotechnology: a review. Virology Journal 10;9:9. doi: 10.1186/1743-422X-9-9.  Impact factor 2.343
  69. Zaidi Nu, Kanwal N, Ghazal A, Fatima K, Javed, F. and Qadri I. (2012)  Phylogenetic and structural analysis of HCV nonstructural protein 4A from Pakistani patients. Virus Genes 2012 Feb;44(1):1-7. doi: 10.1007/s11262-011-0672-y. Impact factor 1.576.
  70. Afzal, M. S., Anjum, S.,  Farooqi, Z. R., Noreen, M., Safi, S, Z. and Qadri, I.  (2012) Association of Interleukin-10 polymorphism and malarial susceptibility in Pakistani Population. Asian Biomedicine 6(3): 337-342   2012 Impact factor 0.33
  71. Afzal, M. S., Anjum, S.,  Farooqi, Z. R., Noreen, M., Safi, S, Z. and , Qadri, I.  (2012) Influence of IL-10 polymorphism on the development of coronary artery disease in Pakistan. Asian Biomedicine 6(2): 159-165. ul 17;6(7):2762-77. doi: 10.3390/v6072762 ul 17;6(7):2762-77. doi: 10.3390/v6072762. Impact factor 0.33
  72. Paracha R, Z., Pervaiz, F., Asalam, B., Obaid, A., Queshi, S., Manzoor, S., Fatima, K. and Qadri I. (2012) Role of Viral Protein-Protein Interactions; possible Targets for new Therapeutics. Journal of Natural Sciences, Vol 2, No. 2, 2012 pp.1-15. Impact factor, not defined yet.

    Publications in 2013
  73. Anjum S, Afzal MS, Ahmad T, Aslam B, Waheed Y, Shafi T, Qadri I. (2013) Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy. Molecular Medicine Reports. Aug;8(2):487-92. doi: 10.3892/mmr.2013.1541. Impact factor 1.554
  74. Iyer A.,  Barbour, E, Azhar,  E., El-Salabi, A, A., , Hassan H. M. A., Qadri I., Chaudhary A.,  Abuzenadah A., Taha Kumosan, T. A.,  Damanhouri,  G., Abdel-Nour, A. M.,  Steve, H (2013) Role of transposable elements in Escherichia coli antimicrobial resistance.  Advances in Bioscience and Biotechnology, 4, 415-423 ABBdoi:10.4236/abb.2013.43A055 Published Online March 2013
    (http://www.scirp.org/journal/abb/). Google-based Journal Impact Factor (2-GJIF) is 0.70
  75. Iyer A., Barbour, E, Azhar,  E., Qadri I., Chaudhary A., Abuzenadah A., Taha Kumosan, T. A.,  Damanhouri, G., Abdel-Nour, A. M., Steve, H (2013) Role of bacteriophages in E. coli antimicrobial resistance.  Advances in Bioscience and Biotechnology, 4, 469-476 doi:10.4236/abb.2013.43A062 Published Online March 2013 (http://www.scirp.org/journal/abb/). Google-based Journal Impact Factor (2-GJIF) is 0.70
  76. Qashqari, H., Al Mars, A., Mahmoud M.,  Zaki M. El Sayed,  Fatima K., Chaudhary A.,  Abuzenadah A., Damanhouri, G., Qadri I.  (2013)  Understanding the Molecular Mechanism(s) of Hepatitis C Virus (HCV) induced Interferon Resistance. Infection, Genetics and Evolution ; 19C:113-119. doi: 10.1016/j.meegid.2013.06.025. Impact factor 3.22
  77. Chaudhry, W,N., Haq. I.U., Andleeb. S. and Qadri, I., (2013) Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water. Journal of Basic Microbiology 014 Jun;54(6):531-41. doi: 10.1002/jobm.201200710. Impact factor 1.823
  78. Anjum, S,, Wahid, A,, Afzal, M.S., Albecka, A., Alsalehm K., Ahmad, T., Baumert. T.F., Wychowski, C., Qadri, I ., Penin F., Dubuisson, J. (2013) Additional Glycosylation within a Specific Hypervariable Region of Subtype 3a of Hepatitis C Virus Protects Against Virus Neutralization. Journal of   Infectious  Diseases. 2013 Dec;208(11):1888-97. doi: 10.1093/infdis/jit376. Impact factor 5.88
  79. Akhtar, H., Akhtar, S., Jan, S. U., Khan A., Zaidi NJ., and Qadri, I. (2013) Over Expression of a sytntheic gene encoding interferon lambada ( IFN L) using relative synonaymous codon usage bias in  in E. coli. Pakistan J of Pharmaceutical Sciences Vol. 26, pp 1181-1188. Impact factor 1.0
  80. Afzal, M. S., Anjum, S.,  Salman, A.,  Ashraf, S.   Farooqi, Z, R.,  Ahmed, T., Waheed, Y and  Qadri, I. (2013) Interleukin-10 gene promoter polymorphism as a potential host susceptibility factor in Pakistani patients with pulmonary tuberculosis Advanced Research Journal of Immunology and Virology. 10/2013; Vol. 1 (3),(Vol. 1 (3),):049-053,
  81. Paracha UZ., Fatima., K., Alqahtani, M., Chaudhary, A., Abuzenadah, A., Damanhouri, G., Qadri I. (2013) Oxidative stress and hepatitis C virus. Virology  Journal 2013 Aug 7;10(1):251. Impact factor 2.44
  82. Fatima K., and Qadri, I. (2013) Battle against Poliovirus in Pakistan.   Journal of Infection in Developing countries  (JIDC) 2013 Nov 15;7(11):897-9. doi: 10.3855/jidc.3647  Source: PubMed Impact factor 1.2
  83. Paracha, U, Z., Qadri, I., Hayat, K., and Hussain T. (2013)  Biomarkers for Alzheimer's Disease and Potential Future Directions Aging and Neurodegeneration 11/2013; 01(01):25-29. Impact Factor, Not defined yet
  84. Harakeh, S. Diab-Assaf, M., Azar, R., Safwan, T., Abou-El-Ardat, K.,. Damanhouri, G, A. and  Qadri,  I., Chaudhary, A., Kumosani, T.,  Mutlak, H. A. H.,  Niedzwiecki, A., Rath, M., Yacoub,  H., Azhar E., and , Barbour E. (2013) Epigallocatechin-3-gallate inhibits Tax-dependent activation of Nuclear Factor Kappa B and of Matrix Metalloproteinase 9 in Human T-cell Lymph trophic Virus 1- positive leukemia cells. Asian Pacific Journal of Cancer Prevention: (APJCP)  15(3):1219-25. Impact factor 2.51

    Publications in 2014
  85. Shah, M.A.A. . Umar, S.,  Iqbal, M.F.,  Rehman, F.,  Qadri I., and  He, N  (2014) Recent developments in DNA vaccination approaches against poultry coccidiosis and its future endeavours World's Poultry Science Journal (WPSJ) 06/2014; Volume 70, Issue 02):pp 315 - 328. Impact factor 1.16
  86. Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL. (2014) Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan. Viruses 2014 Jul 17;6(7):2762-77. doi: 10.3390/v6072762. Impact factor 3.56
  87. Mathew S, Faheem M, Archunan G, Ilyas M, Begum N, Jahangir S, Qadri I, Qahtani MA, Mathew S. (2014) In silico studies of medicinal compounds against hepatitis C capsid protein from north India. Bioinformation Biological  Insights  ISSN: 1177-93222014 Jun 23;8:159-68. doi: 10.4137/BBI.S15211. Impact factor 0.5
  88. Shah. F. A., Fatima, K., Ali, M., and Ali, S and Qadri, I. (2014) Tributyltin(IV)[3-(3',5'-dimethylphenylamido) propanoate] as a Potent HCV inhibitor,  its delivery study, controlled release and binding sites using CTAB as a standard cell membrane. Applied Organometallic Chemistry 2014, 28, 74–80. Impact factor 2.44
  89. Fatima, K., Suhail, M. Ali A., Azar, E., Damanhouri, G., and Qadri, I (2014) Functional Expression and  characterization of  HCV NS3 RNA helicase. Public Library of Science (PLOS)-One. 4;9(9):e106339. doi: 10.1371/journal.pone.0106339. eCollection 2014. Impact factor 3.22
  90. Suhail., M., Abdul Hafiz, H., Ali, A., Fatima, K, Chaudhray, A., Damanhouri, G.,  and Qadri. I (2014) The mechanisms of hepatitis B Virus (HBV) included liver injury.  World Journal of Gastroenterology Aug 14;20(30):10238-10248. Impact factor 2.44
  91. Ali, A., Abdul Hafiz, H., Suahil, M., Al Mars, A., Chaudhray, A., Damanhouri, G. and Qadri, I (2014). The role of HBx mutants in the development of hepatocellular carcinoma. World Journal of Gastroenterology 7(20(29):). DOI: 10.3748/wjg.v20.i29.0000. Impact factor 2.44
  92. Mathew, S., Ali, A., Abdel-Hafiz, H., Fatima, K., Archunan, G.,  Begum, N., Jahangir,S.,  Ilyas, M, Chaudhary,A.,  Al Qahtani M., Bazarah, S., and Qadri I. (2014) Biomarkers for virus induced hepatocellular carcinoma Infection Genetics and Evolution 26C:327-339. doi: 10.1016/j.meegid.2014.06.014. Epub 2014 Jun 21. Impact factor 3.22
  93. Khan, S., Ali, A., Khan S., Zahran, S, A., Azhar, E., Damanhouri G., and Qadri, I (2014) Unraveling the Complex Relationship Triad between Lipids, Obesity, and Inflammation  Mediators of Inflammation 08/2014; Article ID 502749. DOI: 10.1155/2014/502749 Impact factor 3.32
  94. Fatima, K., Azhar, E.,  Mathew. S., and  Qadri, I.  (2014) Comparison of Structural Architecture of HCV NS3 Genotype 1 versus Pakistani Genotype 3a   Biomedical Research International(BMRI) 2014;2014:749254. doi: 10.1155/2014/749254. Epub 2014 Oct 21. Impact factor 2.7
  95. Shah, F, A., Fatima, K., Sabir, S.,  Ali, S. Fischer, A.,   Qadri, I. (2014) Design, synthesis, and Gaussia luciferase Assay of triorganotin(IV)-based HCV inhibitors   Medicinal Chemistry  Research  doi 10.1007/s00044-014-1242- Impact factor 2.4
  96. Zakhria, K., Ali, A., Fatima, K., Azhar, E., Damanhouri, G., and Qadri, I. (2014) Hepatitis B and C virus infection and inflammationJournal of Genetic Syndrome & Gene Therapy ISSN: 2157-7412 5: 241. doi: 10.4172/2157-7412.1000241 Impact factor 2.34

    Publications in 2015
  97.  Mathew, S.,   Fatima, K., Fatmi, M, Q., Archunan, G. Ilyas, M.· Begum, N.,  Azhar, E., Damanhouri, G., and Qadri, I.  (2015) Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds  Public Library of Science (PLOS)-One Jun 1;10(6):e0126510. doi: 10.1371/journal.pone.0126510. eCollection 2015.  Impact factor 3.23
  98.  Saba, K.,  Bukhari, M, H.,  Khaleel, F.,   Imam, S, F.,  Zainab, M.,   Siddiqa, A.,  Ahmad, G.,   and  Qadri, I., (2015)  Muhammad AnwarDetection of HPV and its Association with Different Known Risk Factors for Neoplastic Cervical Lesions  Acta Medica International 01/2015; 2(2):92-99. DOI:10.5530/ami.2015. Impact factor 3.9
  99. Suhail, M., Ali, A., Mathew, S., Shah, A., A., Harakeh, S, M., Ahmad, A., Kazmi, Z., M. A. Rehman., Adeel Chaudhary, A., Damanhouri, G, A., and  Qadri, I. (2015) Nanomaterial Induced Immune Responses and Cytotoxicity Journal of  Nanoscience and Nanotechnology 02/2015; Vol. 15:1-18. DOI:10.1166/jnn.2015.10885 Impact factor 1.60
  100. Mathew, S. and  Qadri, I.  (2015) Quantitative structure activity relationship and molecular docking analysis of cholesterol inhibitors against niemann-pick c2 target gene (npc2)  International Journal of Advances in Pharmaceutical Research 03/2015; 6(9):2320-5148. DOI:10.13040/IJPSR.0975-8232.6(9).1000-08 Impact factor 1.69
  101. Mathew, S. and  Qadri, I. (2015) Updates on Peptide Vaccines. International Journal of vaccine and vaccinology  1-1, 2015, 1-2
  102. Mathew, S., Faheem, M., Al-Malki, A., Kumosani, T. A. and  Qadri, I. (2015) In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds Bioinformation 04/2015; Volume 11(4)(4). DOI:10.6026/97320630011189 Impact factor 0.67
  103. Hariharan, M., lyas, M., Hussain, M., kumpati, P. K., Begum, N.T., Mathew, S., and Qadri, I. (2015) Chemical composition of the hexane extract of leaves of Azima tetracantha (LAM)
    International Journal of Pharmacy and Pharmaceutical Sciences 04/2015; 7(5):1-5.  Impact factor 1.6 
  104. Shah, F. A.,   Sabir, S.,  Fatima, K., Ali, S.,  Qadri, I.  and Rizzoli, C (2015)  Organotin(IV) based Anti-HCV drugs: Synthesis, Characterization and Biochemical Activity  Dalton Transactions 2015 Jun 14;44(22):10467-78. doi: 10.1039/c5dt00862j.  Impact Factor 4.20
  105. Mathew, S.,   Shaabad, M.,   Hussain, S.,  Mira, L. and   Qadri, I.   (2015) The Need behind Messenger RNA Sequencing Analysis  International Journal of Advanced Research 06/2015; 3(6):1260-1270. Impact Factor 4.59
  106. Mathew, S.,   Mathew, S.,   Hamed, M. H. and  Qadri, I.   (2015) A web based decision support system driven for the neurological disorders   International Journal Of Engineering Research and General Science 07/2015 Impact Factor  3.84
  107. Zia, A.  Raza, A.,   Ullah, A.,  Ali, S.,  Mathew, S.,    Fatima, K. and  Qadri, I.  (2015) Prevalent risk factors of HCV transmission in Health Care Workers (HCWs) in Pakistan   International Journal of Pharmacy and Pharmaceutical Sciences 07/2015.  Impact Factor 1.59
  108. Sheikh, T. I.,   Adam, T. and  Qadri, I. (2015) Up-regulated hepatic expression of mitochondrial PEPCK triggers initial gluconeogenic reactions in the HCV-3 patients.  Asian Pacific Journal of Tropical Medicine 2015 Aug;8(8):618-23. doi: 10.1016/j.apjtm.2015.07.016. Epub 2015 Jul 2.  Impact factor 1.20
  109. Shah, M. A. A.,  Ali, Z.,   Ahmad, R.,  Qadri, I.,  Fatima, K. and   He, N. (2015) DNA Mediated Vaccines Delivery Through Nanoparticles.  Journal of Nanoscience and Nanotechnology 09/2015; 15,:41-53. DOI:10.1166/jnn.2015.9603. Impact Factor 1.56
  110. Shah, F. ,A.,  Fatima, K.,  Ali, S. and  Qadri, I. (2015)  Design, Synthesis,  and Delivery Studies of Organotin(IV) based HCV Inhibitor.  Infectious Disorders - Drug Targets  Volume 15 number 3.  Impact factor 2.4
  111. Vincent, N., Mathew, S., Mathew, S., Qadri, I. (2015) Reconstruction of 3D model from 2D surveillance images International Journal Of Engineering Research and General Science 09/2015.
  112. Mathew, S.,  Vincent, N.,  Mathew, S. and  Qadri, I. 2015)  Medical decision support system for typhoid diagnosis International Journal Of Engineering Research and General Science 09/2015. Impact Factor 3.84
  113. Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. Hepatitis C virus and neurological damage. World J Hepatol. 2016 Apr 28;8(12):545-56. doi: 10.4254/wjh.v8.i12.545
  114. Rubi, G., Mathew, S., Qadri, I. (2015) Genetic susceptibility of HCV RNA  in various isonym groups of Punjab, Pakistan.  International Journal of Pharmacy and Pharmaceutical Sciences Vol 7, Issue 12, ISSN-0975-1491.  
  115. Shah, F. A.,  Fatima, K.,  Sabir, S.,  Ali, S.,  Qadri, I.,  ud-din.   N. (2015) Design, synthesis, structure information and biochemical activity of new floro substituted organotin(IV) carboxylates.    Journal of Photochemistry and Photobiology B Biology 10/2015; JPB 10168:S1011-1344(15)00332-2. DOI:10.1016/j.jphotobiol.2015.10.011.  Impact Factor 2.96
  116. Mathew, S.,  Fatima, K., and Qadri, I. (2015) Challenge hepatitis C with herbs as drugs  Medical Sciences Ms. No.15-1424 impact factor 1.
  117. Hariharan, M.,  lyas, M.,  Hussain, M.,   kumpati, P. K.,  Begum, N.T.,   Mathew, S.,  and Qadri, I. (2015) Chemical composition of the hexane extract of leaves of Azima tetracantha (LAM)   International Journal of Pharmacy and Pharmaceutical Sciences 04/2015; 7(5):1-5).
  118.  Mathew, S.,   Shaabad, M.,   Hussain, S.,  Mira, L. and   Qadri, I.   (2015) The Need behind Messenger RNA Sequencing Analysis  International Journal of Advanced Research 06/2015; 3(6):1260-1270.
  119. Mathew, S., Mathew, S., Hamed, H. M., & Qadri, I. (2015). A web based decision support system driven for the neurological disorders. International journal of engineering research and general science, 3 (4), 177-192.  
  120. Zia, A.  Raza, A.,   Ullah, A.,  Ali, S.,  Mathew, S.,    Fatima, K. and  Qadri, I.  (2015) Prevalent risk factors of HCV transmission in Health Care Workers (HCWs) in Pakistan   International Journal of Pharmacy and Pharmaceutical Sciences Vol 7, issue 10 ISN-0975-1491  07/2015.  
  121. Mathew, S., Ilyas, M.,  Archunan, G., Begum, N., Suhail, M.,  Fatima, K. and Qadri, I. (2015) Updates on Traditional Medicinal Plants for Hepatocellular carcinoma. Frontiers in Pharmacology & Ethnopharmacology Volume 8, Issue 3, 203-214

    Publications in 2016
  122. Mathew, S., Faheem M., Suahil, M., Fatima, K., Archuan, G., Begum N., Ilyas, M., Azhar, E., Damanhouri, G and Qadri, I. (2016) Updates on tradtitional medicinal plants for hepatocellular carcinoma. Pharmacology 2016, DOI: 10.5530/pj.2016.3.5
  123. Yakob, A, A., Begum N., Ilyas, M., Mathew, S., and Qadri, I (2916) Green synthesis, Antioxidant Potential and Hypoglycemic Effect of Silver Nanoparticles Using Ethanolic Leaf Extract of Clausena anisata(Willd.) Hook. F. Ex Benth. of rutaceae.   Pharmacognosy Journal 8(6) · July 2016 DOI: 10.5530/pj.2016.6.8
  124. Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. (2016) Hepatitis C virus and neurological damage.  World J. Hepatol.  Apr 28;8(12):545-56. doi: 10.4254/wjh.v8.i12.545.
  125. Mathew S, Abdel-Hafiz H, Raza A, Fatima K, and Qadri I. (2016) Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.  World J Hepatol.  Apr 8;8(10):485-98. doi: 10.4254/wjh.v8.i10.485.
  126. Shah FA, Fatima K, Sabir S, Ali S, Qadri I, ud Din N. (2016)  Design, synthesis, structure information and biochemical activity of new floro substituted organotin(IV) carboxylates. J Photochem Photobiol B. 2016 Jan;154:99-107. doi: 10.1016/j.jphotobiol.2015.10.011. Epub 2015 Oct 17.
  127. Hamed. H.,  · Rehman,S.,  Qadri, I. (2016)  Challenges to Treat Interferon Resistance in Hepatitis C Virus Infected Patients Vol 1 page 1. doi  http://dx.doi.org/10.16966/ijmbm.e102
  128. Yakob, A., Begu, N., Mathw, S., Ilyas, A., Qadri, I (2016) Gc-Ms Analysis of Ethanolic Stem Extract of Clausena anisata (Willd.) Hook F Ex Benth.  Pharmacognosy Journal 8(6) · July 2016 DOI: 10.5530/pj.2016.6.9
  129. Ilyas, M.,  Archunan, G., Begum, N., Suhail, M.,  Mathew, S. and Qadri, I (2016) Synthesis of plant mediated gold nanoparticles using Azima tetracantha    Lam. leaves extract and evaluation of their antimicrobial activities  pharmacognosy J. in press IF (1.44)
  130. Riaz, M., N., Faheem, M Anwar, M. A., Raheem, U., Badshah, Y., Akhtar, H.,  Tamanna, K., Tahir, M., Zaidi, N, S. S,  and Qadri I.  (2015) Clinical Profiling and PCR Based Molecular Diagnosis of HBV and HDV in HCV Infected Patients.  Journal of Pathogens 2016;2016:3219793. doi: 10.1155/2016/3219793
  131. Mathew, S  Fatima, K., and Qadri, I. (2016) Challenge hepatitis C virus with herbs as drugs  Traditional Medicine and clinical Naturopathy, 5: 1, 180-184
  132. Hammed M., Raehman, S., and Qadri I. (2016) Challenges to treat interferon resistance in hepatitis C virus infected patients Inter. J. of Mol. Biol. and Medicine  volume 1: 1-2 
  133. Rehman, S. R., Rauf, M., Abbas, Z., Hameed, M. H., Qadri, I. (2016) Role of some predominant host immunomodulators single nucleotide polymorphisms in severity of hepatitis B and V virus infection.  Viral immunology volume 29, page 1-10 DOI.10.1089/vim.2016.0062.

    Publications in 2017
  134. Hameed H., Pushparaj, P., N., Bazarah, S., Karim, S., Alghamdy, K., Qadri, I. (2017) Decoding the role of serum IL12 as prognostic biomarkers in pegylated IFN-a/ribavirin treated chronic hepaotis C patients using Luminexx MAP technology Adv. Res. Gastro. & Hepatology Volume 2, issue 3, 001-003 doi 10.19080.ARGH.2017.02.55589.
  135. Khan M. Y., Khan N., Farman, M., Al karaim, M., Qadri, I., Amjad, M. Alghamdi, K., Harakah, S., HTLV-1 associated neurological disorders Current Topics in Medicinal Chemistry 2017;17(12):1320-1330. doi: 10.2174/1568026616666161222141318
  136. Damiati, S., Kupcu, S., Peacock, M., Eilenberger, C., Zamzami, M., Qadri, I.,  Choudhray, H., Sleytr, U. B., and Schuster, B., (2017) Acoustic and hybrid 3D printed electrochemical biosensors for the real-time immunedetection of liver cancer cells (HepG2) Biosensors, and Bioelectronics, 94, 500-506http://dx.doi.org/10/.1016/j.bios.2017.03.045
  137. Kanwal, F., Simair, A. A., Chen T., Zhang, Y. L., Qadri, I., Lu, c. (2017) Molecular Cloning and In silco analysis of hIL6 gene from Pakistan Dengue Hemorrhagic fever patients. MOJ Immunology, 5(5):00170-00174. DOI:10.15406/moji.2017.05.00170
  138. Kanwal, F., Lu C., Qadri, I., Sohail, M., Farooqi Z ur R. (2017) Interleukin-6: A promising disease severity index for dengue virus infection Asian Pacific J of Tropical Medicine, 7(5) 930-933. DOI.10.12980/apjtd.7.201706.461
  139. Rehman S. R., Ahmed, S., Hameed, and Qadri, I (2017) Hepatitis C Virus Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy Related Cardiopulmonary Toxicity. Viral immunology Nov;30(9):633-641. doi: 10.1089/vim.2017.0009.

    Publications in 2018
  140. Sohrab, S, S., Suhail, M., Al, A., Qadri, I., Harakah, S., Azhar, E, I. (2018) Consequence of HIV and HCV coinfection on host immune response, persistence and current treatment options Virus Disease http://doi.org/10/1007/s13337-018-x
  141. Mathew, S., Faheem M., Hameed, H.M., Natarajan, S., Iqbal, W., Arjuna, G., Fatima, K., Qadri, I. (2018) Association and linkage of various retroviruses and it progression towards neurodegeneration Int. J. Pharm Res. 10 17-30
  142. Fatima, K., Mathew, S., Suhail, M., Azhar, E., Damanhouri, G., Qadri, I (2018) Architecture of viral helicases: HCV as antiviral target. Int. J. Pharm Res. 10, 31-39
  143. Akhtar, A, Badshah, Y., Akhtar, S., Hasan F., Faisal, M., Zaidi N , S S., and  Qadri, I. (2018) Prevalence of hepatitis B an dC viruses infections among male to female (MFT) trans genders in Rawalpindi (Pakistan) Adv. Life Sci, 5, 46-55
  144. Suahil, M., Soharab, S. Qadri, I (2018) Viral and host Single nucleotide polymorphism (SNP) associated with HCV induced hepatocellular carcinoma. Infection Genetics &  Evolution in pres
  145. Vijaykumar, K., Rengarajan, R. L., Radhakrishanan, R., Mathew, S., Qadri, I., and Anad, A. V. Psidium guajava leaf extracst and their Quercetin protect HepG2 cell lines against CCL4 induced cytotoxity Ind J. of Clin. Biochem 11 April 2018, https://doi.org.10.1007/s12291-018-0752-z
  146. Hakami, A., Qadri, I., Chakravatory, N., Al-Ghamdy, K., Al Hindi, R. (2018) Molecular Detection of White Spot Syndrome Virus (WSSV) from Farmed Shrimps in Saudi Arabia. Cohesive J. of Microbiology and Infectious Disease ISSN 2578-0190. Vol 5, 1-7